Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

AIMS: Most cardiac surgery patients, with or without diabetes, develop perioperative hyperglycaemia, for which intravenous insulin is the only therapeutic option. This is labour‐intensive and carries a risk of hypoglycaemia. We hypothesized that preoperative administration of the glucagon‐like pepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulst, Abraham H., Visscher, Maarten J., Godfried, Marc B., Thiel, Bram, Gerritse, Bastiaan M., Scohy, Thierry V., Bouwman, R. Arthur, Willemsen, Mark G. A., Hollmann, Markus W., Preckel, Benedikt, DeVries, J. Hans, Hermanides, Jeroen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079116/
https://www.ncbi.nlm.nih.gov/pubmed/31749275
http://dx.doi.org/10.1111/dom.13927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079116/
https://www.ncbi.nlm.nih.gov/pubmed/31749275
http://dx.doi.org/10.1111/dom.13927

Ejemplares similares